EFPIA, Transparency Activists Praise EU Clinical Trial Regulations

Drug Industry Daily
A A
European drug companies and transparency advocates alike are praising the clinical trials legislation advancing through the EU Parliament, with Europe’s largest pharma lobbying group saying the proposal as it now stands will dramatically improve clinical trial efficiency in the EU.

To View This Article:

Login

Subscribe To Drug Industry Daily